.webp&w=3840&q=75)
Bioprocessing of New Medicines (Business and Management)
The Bioprocessing of New Medicines (Business and Management) program at University College London (UCL) is a 3-year, full-time Bachelor of Science degree that combines the technical aspects of bioprocessing with business and management principles. This unique program equips students with the knowledge to manage the complex processes involved in developing new medicines, from the laboratory to commercialization.
By integrating scientific understanding with business strategy, this program prepares graduates to take leadership roles in the rapidly growing pharmaceutical and biotechnology industries.
Key information
Key Facts
Program Title: Bachelor of Science in Bioprocessing of New Medicines (Business and Management)
Degree Type: Bachelor of Science
Duration: 3 years
Mode of Study: Full-time, On Campus
Application Deadline: 29th January 2026
Location: University College London, United Kingdom
Field of Study: Business Administration
Language of Instruction: English
Program Structure
The Bioprocessing of New Medicines (Business and Management) program is designed to provide both scientific and business acumen. In the first two years, students will gain foundational knowledge in bioprocessing, biotechnology, and business management. In the final year, students will focus on advanced topics such as regulatory affairs, supply chain management in biopharma, and business strategies for new medicines. A hands-on project and industry placement will allow students to apply their learning to real-world challenges.
Career Opportunities
Graduates of the Bioprocessing of New Medicines (Business and Management) program are well-prepared for careers in the pharmaceutical and biotechnology sectors, particularly in roles related to product development, operations management, and regulatory affairs. Opportunities include positions in pharmaceutical companies, biotechnological firms, healthcare consulting, and research institutions.
Why Choose This Program
UCL’s Bioprocessing of New Medicines (Business and Management) program offers a distinctive education that combines science with business expertise. Students benefit from UCL’s strong connections to the pharmaceutical industry, access to cutting-edge research, and expert faculty, making them well-equipped to address the challenges of developing new medicines in a competitive global market.
Contact Information
For further information, please contact the admissions office at:
Phone: +44 (0)20 7679 2000
Email: study@ucl.ac.uk
Address: University College London, Gower Street, London WC1E 6BT, United Kingdom
